Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
Medmo and Covera Health, both based in New York, officially announced their merger on April 21, with the latter’s lead investor, Insight Partners, funding the deal.
By and large, U.S. hospitals and health systems do not have an AI adoption problem. But many—if not most—have an execution problem: They struggle to turn a set of installed AI tools into a measurable operational value.
Family physicians and other primary care providers don’t mind being held to account for care quality by healthcare administrators. The rub is that multiple other stakeholders often demand similar levels of answerability, pulling the doctors in different directions at once.
Developed by a board-certified diagnostic and interventional radiologist, the platform was trained using subspecialty data that general AI applications typically lack.
Christoph Wald, MD, vice chair of the American College of Radiology Board of Chancellors, explains the resources available to practices looking to bolster cybersecurity.
Although the company is already bringing in revenue from medical radioisotopes, the new funding will help further these initiatives and drive additional research and development.
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.
Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
